Latest Trials

Systemic therapy trial

LEAP-007 : A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) With or Without...

This phase III trial is evaluating the safety and effectiveness of a type of immunotherapy (Pembrolizumab) alone and in combination with an oral targeted therapy (Lenvatinib) in patients who have received no prior treatment for metastatic non-small cell lung cancer

Status : Recruiting

Systemic therapy trial

POTOMAC : A Phase III Randomized, Open-Label, Multi-Center, Global Study of Durvalumab and Bacillus...

This phase III trial is trying to determine whether the combination of an immunotherapy (Durvalumab) and a standard of care therapy (Bacillus Calmette-Guerin) is better than giving standard of care therapy alone, in the treatment of non-muscle-invasive bladder cancer

Status : Recruiting

Systemic therapy trial

A Phase 2, Open-Label Study of Intratumoral Tavokinogene Telseplasmid Plus...

This phase II trial is evaluating a biological therapy (Tavokinogene Telseplasmid - delivered by electroporation), in combination with an immunotherapy drug (Pembrolizumab), in patients with advanced triple negative breast cancer

Status : Recruiting

Systemic therapy trial

ATTAIN : A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 Versus Treatment of...

This phase III trial is comparing the drug NKTR-102 with a treatment chosen by the doctor in patients who have have been treated for breast cancer that has spread to the brain

Status : Recruiting

Systemic therapy trial

ZUMA-7 : A Phase 3, Randomized, Open-Label Study Evaluating Efficacy of Axicabtagene Ciloleucel...

This phase III trial is comparing the effectiveness of a biological therapy (Axicabtagene Ciloleucel) and standard of care chemotherapy in Diffuse Large B-Cell Lymphoma patients who have gotten worse or not responded to prior treatment

Status : Recruiting

Systemic therapy trial

A Phase I/Ib, Study to Evaluate Safety and Efficacy of RP4010, in Patients With Relapsed...

This phase I trial is testing escalating doses of a new oral therapy (RP4010) in lymphoma patients who have gotten worse or not responded to prior treatment

Status : Recruiting

Systemic therapy trial

15834 – ARCS Multi-Tumour : Phase 1b Multi-indication Study of Anetumab Ravtansine (BAY94-9343) in Patients With...

This phase I trial is trying to determine the safety and effectiveness of an immunotherapy drug, given alone and as a combination therapy for mesothelin-expressing advanced cancers

Status : Recruiting

Systemic therapy trial

A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of MGD013, A Bispecific DART...

This phase I trial is trying to determine how safe and tolerable a new therapy (MGD013) is for treating patients with advanced cancers

Status : Recruiting

Systemic therapy trial

ACE-CL-311 : A Randomized, Multicenter, Open-Label, Phase 3 Study to Compare the Efficacy and Safety...

This phase III trial is comparing two combination treatments with a chemoimmunotherapy (as chosen by the investigator) in patients with newly diagnosed Chronic Lymphocytic Leukaemia

Status : Recruiting

Systemic therapy trial

MAGNITUDE : A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination...

This phase III trial is trying to determine how effective an oral therapy (niraparib) is in combination with a hormone therapy and a steroid (abiraterone acetate and prednisone, AA-P) in patients with metastatic prostate cancer

Status : Recruiting

 

Looking for a trial? Use the search functionality to find the trial you are finding.